Researchers at the University of Virginia Health System have defined a molecular mechanism by which the activity of low-voltage-activated calcium channels can be decreased. Low-voltage-activated, T-type calcium channels are found in many types of tissue and alterations in their activity can contribute to several pathological conditions, including congestive heart failure, hypertension, cardiac arrhythmias, epilepsy and neuropathic pain. The findings will be published in the July 10 edition of Nature. The team led by Paula Q. Barrett, professor of pharmacology and principle investigator of the study, found that G-protein beta gamma subunits, a class of cell membrane proteins that mediate the actions of hormones within the cell, markedly decrease the flow of calcium through these channels into the cell interior. Because elevation of calcium within cells stimulates cellular activity, regulation of calcium entry is an important way by which the function of cells can be controlled. The research uncovered that only one member of a large family of G-protein subunits binds directly to the calcium channel protein to inhibit channel activity.
"These studies identify the T-type calcium channel as a new target for G-protein beta gamma subunits," Barrett said. "The extraordinary specificity of the interaction between these regulatory molecules could be operative in many types of cells and provides exciting insight into the highly selective ways in which cells work. Knowledge of these interactions will lead to the development of new and more specific drugs in the future."
Abena Foreman-Trice | EurekAlert!
Repairing damaged hearts with self-healing heart cells
22.08.2017 | National University Health System
Biochemical 'fingerprints' reveal diabetes progression
22.08.2017 | Umea University
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
22.08.2017 | Health and Medicine
22.08.2017 | Materials Sciences
22.08.2017 | Life Sciences